AS 0369
Alternative Names: AS-0369Latest Information Update: 28 Dec 2023
Price :
$50 *
At a glance
- Originator Albireo Pharma
- Class Urologics
- Mechanism of Action Sodium-bile acid cotransporter inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Kidney disorders
Most Recent Events
- 10 Nov 2023 Updated pharmacodynamics data from a preclinical trial in Kidney disorders presented at the 74th Annual Meeting of the American Association for the Study of Liver Diseases(AASLD-2023)
- 21 Jun 2023 Preclinical trials in Kidney disorders in USA (PO) before June 2023
- 21 Jun 2023 Pharmacodynamics data from a preclinical study in Cholestasis presented at the European Association for the Study of the Liver Congress 2023 (EASL-2023)